Stereotactic Surgery Devices Market - Top Companies and Manufacturers

  • Report ID: 5331
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Companies Dominating the Stereotactic Surgery Devices Landscape

    • Koninklijke Philips N.V.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Hitachi Medical Systems
    • Huiheng Group
    • Siemens AG
    • Elekta AB
    • Varian Medical Systems
    • IBA
    • Accuray Incorporated
    • GE Healthcare
    • Toshiba Energy Systems & Solutions Corporation

Browse Key Market Insights with Data Illustration:

In the News

  • Siemens AG announced to acquisition of Varian Medical Systems, Inc. to create a highly integrated portfolio of imaging, laboratory diagnostics, and artificial intelligence for the treatment of cancer, and establish a strong and trusted partner capable of supporting customers and patients across the entire cancer care. Furthermore, the acquisition will enable the company to address the growing need for personalized, data-driven diagnosis and precision cancer care and support oncology clinicians and patients in achieving better outcomes.
  • Varian Medical Systems, Inc. announced that it has obtained clearance from the FDA for the use of the first linear accelerators TrueBeam and Edge systems that are intended to accurately target tumors and other diseases using radiation. Furthermore, TrueBeam and Edge systems will be used to treat medically refractory essential tremors with stereotactic radiosurgery to improve the lives of many patients who might otherwise be forced to live with untreatable essential tremors.

Author Credits:  Radhika Pawar


  • Report ID: 5331
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of stereotactic surgery devices is evaluated at USD 29.64 billion.

The stereotactic surgery devices market size was over USD 28.77 billion in 2024 and is poised to exceed USD 46.72 billion by 2037, witnessing over 3.8% CAGR during the forecast period i.e., between 2025-2037. Rising cases of cancer across the globe and growing technological advancements will drive the market growth.

North America industry is expected to account for largest revenue share of 42% by 2037, impelled by rising government initiative to increase cancer awareness in the region.

The major players in the market include Koninklijke Philips N.V., Hitachi Medical Systems, Huiheng Group, Siemens AG, Elekta AB, Varian Medical Systems, IBA, Accuray Incorporated, GE Healthcare, Toshiba Energy Systems & Solutions Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample